bilaterales Myelolipom der Nebennieren

bilaterales Myelolipom der Nebennieren

Myelolipom Nebenniere RadiopaediaCC-by-nc-sa 3.0de

Adrenal myelolipomas are rare, benign and usually asymptomatic tumors of the adrenal gland characterized by the predominance of mature adipocytes.

On imaging, they usually present as large masses with a variable amount of fat-containing components.


Rare tumors with estimated autopsy prevalence of 0.1-0.2%. They are usually identified in adults, either incidentally or if complicated by hemorrhage (see below). There is no gender predilection .

Clinical presentation

Most lesions are asymptomatic  and may be discovered incidentally when the region is imaged for other reasons (i.e. an incidentaloma). Larger lesions (typically over 4 cm in size) can present with an acute retroperitoneal hemorrhage, and still others (especially when very large) with vague mass-related symptoms . There may be a right-sided predilection .

Although the tumor itself is non-functioning there is a relatively high incidence (10%) of associated endocrine disorders :


Histological examination demonstrates variable amounts of:

  • mature adipocytes (with distended lipid vacuoles) similar to bone marrow
  • hematopoietic cells (including cells from myeloid, erythroid and megakaryocytic cell lines)

The fatty component is often the predominant feature and therefore the most characteristic feature on imaging. The lesions can infrequently contain bone or show partial replacement by hemorrhage or fibrosis.

Radiographic features


Exact sonographic appearances are varied depending on individual tumor components . Usually is seen as a heterogeneous mass of mixed hyper- and hypoechoic components with the former primarily resulting from fatty portions. Areas of hemorrhage appear hypoechoic on ultrasonography .


The CT appearance is usually characteristic. The typical adrenal myelolipoma appears as an adrenal lesion with fat-containing components. The mass is usually relatively well circumscribed, however masses that are mostly fat may be difficult to separate from surrounding retroperitoneal fat.

The amount of fatty component is variable, ranging from only a few small regions in an otherwise mostly soft tissue density mass (10%) to masses made up of roughly equal components of fat and soft tissue (50%) or almost completely composed of fatty tissue (40%) . The soft tissue and fatty components can be sufficiently mixed in some cases to render the mass a density similar to fluid.

Small punctate calcifications may be seen in 25-30% of cases .

If hemorrhage is present then regions of higher attenuation may be seen. This is more frequently seen in large lesions (>10 cm) .

  • T1: typically hyperintense due to fat contents
  • T1 (FS): typically shows fat suppression
  • T2: generally intermediate to hyperintense but can sometimes vary depending on contents (especially blood products) 
  • T1 C+ (Gd): shows striking enhancement
  • in and out of phase: in masses with mixed components, out of phase imaging may demonstrate signal loss as the microscopic fat cells usually have little intracellular water
Nuclear medicine

Adrenal myelolipomas typically do not demonstrate avid FDG uptake and it is generally lower than that of the liver background. However, in rare cases the adenomatous and hematopoietic elements can show an increased FDG uptake .

Treatment and prognosis

They are benign lesions histologically and there is currently no recognized malignant potential . As such, if imaging features are characteristic and the lesion is small, no treatment is required.

If imaging findings are indeterminate, percutaneous biopsy can be performed. In larger lesions or where hemorrhage has occurred surgical excision is curative.

History and etymology

Initially described by Edgar von Gierke in 1905 with the term myelolipoma coined by the French pathologist Charles Obenling (1895-1960) in 1929 .

Differential diagnosis

General imaging differential considerations include:

Siehe auch: